These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 11585010

  • 1. Treatment options in Waldenström's macroglobulinaemia: the role of the purine analogues.
    Owen RG.
    Expert Opin Pharmacother; 2001 Jun; 2(6):945-52. PubMed ID: 11585010
    [Abstract] [Full Text] [Related]

  • 2. Alkylating agents for Waldenstrom's macroglobulinaemia.
    Yang K, Tan J, Wu T.
    Cochrane Database Syst Rev; 2009 Jan 21; (1):CD006719. PubMed ID: 19160296
    [Abstract] [Full Text] [Related]

  • 3. Purine nucleoside analogs: emerging roles in indolent lymphoproliferative disorders.
    Tallman MS, Hakimian D.
    Blood; 1995 Oct 01; 86(7):2463-74. PubMed ID: 7670093
    [No Abstract] [Full Text] [Related]

  • 4. Purine analogs in chronic lymphocytic leukemia and Waldenström's macroglobulinemia.
    O'Brien S, Kantarjian H, Keating MJ.
    Ann Oncol; 1996 Oct 01; 7 Suppl 6():S27-33. PubMed ID: 9010576
    [Abstract] [Full Text] [Related]

  • 5. Fludarabine in Waldenstrom's macroglobulinemia.
    Leblond V, Choquet S.
    Semin Oncol; 2003 Apr 01; 30(2):239-42. PubMed ID: 12720144
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Waldenström's macroglobulinemia.
    McKenna JA.
    Clin J Oncol Nurs; 2002 Apr 01; 6(5):283-6. PubMed ID: 12240489
    [Abstract] [Full Text] [Related]

  • 12. Treatment of Waldenstrom's macroglobulinemia with nucleoside analogues.
    Dimopoulos MA, O'Brien S, Kantarjian H, Estey EE, Keating MJ, Alexanian R.
    Leuk Lymphoma; 1993 Apr 01; 11 Suppl 2():105-8. PubMed ID: 7907250
    [Abstract] [Full Text] [Related]

  • 13. Waldenström's macroglobulinaemia.
    Johnson SA, Oscier DG, Leblond V.
    Blood Rev; 2002 Sep 01; 16(3):175-84. PubMed ID: 12163003
    [Abstract] [Full Text] [Related]

  • 14. Phase III study of chlorambucil versus fludarabine as initial therapy for Waldenstrom's macroglobulinemia and related disorders.
    Johnson SA, Owen RG, Oscier DG, Leblond V, Levy V, Jaeger U, Seymour JF.
    Clin Lymphoma; 2005 Mar 01; 5(4):294-7. PubMed ID: 15794869
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparative efficacy of the newer nucleosides (fludarabine, 2'-deoxycoformycin, and 2-chlorodeoxyadenosine) in the treatment of indolent lymphoid malignancies.
    Saven A.
    Semin Hematol; 1993 Oct 01; 30(4 Suppl 6):31-3. PubMed ID: 7908757
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.